Value of <sup>18</sup>F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype.

EJNMMI Res · 2021 · PMC8609064 · PMID 34807395

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Similar to many previous studies, we report a clear trend with the highest 18 F-FDG uptake in the TN subtype, followed by HER2-positive and ultimately ER-positive/HER2-negative [ 13 , 14 , 16 , 32 – 34 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.